Oxford Expression Tech, Eden Biodesign Form Co-marketing Pact | GenomeWeb
Home » Oxford Expression Tech, Eden Biodesign Form Co-marketing Pact

Oxford Expression Tech, Eden Biodesign Form Co-marketing Pact

Feb 02, 2009

NEW YORK (GenomeWeb News) — Oxford Expression Technologies and Eden Biodesign have struck a co-marketing agreement to serve pharmaceutical researchers involved in protein expression.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Sep 14, 2016

FactBio Seeks to Standardize Data Curation Market With Kusp Platform Launch

Premium
May 05, 2016

5AM Solutions Refocuses on Product Development, Preps for Beta of Data-Management Software

Premium
Jan 20, 2016

Elsevier Continues Focus on Pharmacovigilance, Updates Sequence Analysis Software

Premium
Aug 10, 2016

Repositive, AstraZeneca Partner on PDX Resource; Platform Launch Expected in Q3 2016

Premium
Jun 06, 2016

Illumina to Distribute ArcherDx Oncology Assays Worldwide

Jul 18, 2016

Mobidiag Borrows €15M to Launch Novodiag Platform, IVD Tests

The Scan

This Week in Science

In Science this week: global genetic diversity map, and more.

To Follow Up On

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

Look into the (Possible) Future

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Urged to Amend

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.

What's Popular?

In Proteomics & Protein Research

  1. David Hoffmeister, Bernd Brust, Peter Leddy, Mark O’Donnell, John Cottingham, Paul Grossman, Joe Beery, Brian Pollock, Mark Smedley, Helen Park, Steven Rash, Ira Goldknopf

    Premium

  2. Recent Patents of Interest in Proteomics

    Premium

  3. Kinaxo To Analyze Protein PTMs for Boehringer Ingelheim

  4. U Michigan’s Lubman Turns Attention from Mass Specs to Glycoprotein Microarrays

    Premium

  5. Prolexys Raises $20M to Develop Cancer Drug

Sponsorships

Privacy Policy.  Copyright © 2016 Genomeweb LLC.  All Rights Reserved.